Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Share-based Compensation (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Share-based Compensation for 6 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 51.22% year-over-year to $2.3 million, compared with a TTM value of $9.1 million through Dec 2025, up 45.3%, and an annual FY2025 reading of $9.1 million, up 45.3% over the prior year.
  • Share-based Compensation was $2.3 million for Q4 2025 at Viemed Healthcare, up from $2.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $2.3 million in Q2 2025 and bottomed at $1.2 million in Q2 2021.
  • Average Share-based Compensation over 5 years is $1.6 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Share-based Compensation decreased 0.85% in 2024, then skyrocketed 61.38% in 2025.
  • Year by year, Share-based Compensation stood at $1.3 million in 2021, then increased by 0.92% to $1.3 million in 2022, then increased by 16.48% to $1.5 million in 2023, then decreased by 0.85% to $1.5 million in 2024, then soared by 51.22% to $2.3 million in 2025.
  • Business Quant data shows Share-based Compensation for VMD at $2.3 million in Q4 2025, $2.2 million in Q3 2025, and $2.3 million in Q2 2025.